Prescribing just got smarter.
E-prescribing. EPCS. Easy. Treat is a reinvention of electronic prescribing (e-prescribing) – with a streamlined design and enhanced clinical features that include revamped contraindication alerts, weight-based dosing, and access to an expansive library of medications.
With the power of Ayva, it’s never been easier to write, authorize, track, and send secure prescriptions from anywhere. Treat offers the perfect, intuitive environment to quickly create e-prescriptions. All the right tools are in the right places, so it’s easy to add patients, select drugs, and sign prescriptions. And everyone in your practice has access to the same powerful features.
Focus on healing.
Treat is the most intuitive e-prescribing app ever created. A streamlined design is motivated by a sharpened focus on efficiency and functionality. Your most frequently prescribed medications can be saved as favorites, accessible when and where you need them. And Treat is adaptable to your workflow, so you can write digital prescriptions in record time.
Up and running. Fast.
Treat runs as a standalone app on the Ayva platform. Improve your patient’s experience and meet state mandates without being forced to adopt clunky electronic health record (EHR) software. Just sign up and start sending e‑prescriptions today.
Take control of controlled substances–with Treat.
Sign and send e-prescriptions for Schedule II-V controlled and non-controlled substances easily with Treat. Two-factor authentication ensures every prescription is protected and secure. And providers can put their trust in Treat with EPCS certification that meets federal and state requirements in all 50 states.
Over-the-counter medications and low-risk medications that are prescribed to treat medical conditions such as high blood pressure, diabetes, and bacterial infections. Prescriptions for non-controlled substances are not subject to the same limitations as controlled substances.
Ibuprofen, labetalol (Trandate), ondansetron (Zofran), cefdinir (Omnicef)
Drugs, substances, or chemicals with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics.
cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin
Drugs, substances, or chemicals with a low potential for abuse and low risk of dependence.
Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol
Drugs, substances, or chemicals with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV.
Products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone
Drugs, substances, or chemicals with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous.
Combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin
Drugs, substances, or chemicals with no currently accepted medical use and a high potential for abuse. Schedule I substances cannot be prescribed with Treat.
Examples: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote
Intelligent clinical support.
Treat includes built-in clinical decision support for the entire drug library. Each prescription is automatically checked for drug-drug, drug-allergy, duplicate therapy, age, and pregnancy contraindications. Treat’s Smart Alert system delivers meaningful alerts at precisely the right time.